Testicular seminoma after the complete remission of extragonadal yolk sac tumor : a case report
© Kuroda et al; licensee BioMed Central Ltd. 2004
Received: 31 May 2004
Accepted: 16 November 2004
Published: 16 November 2004
Between 2% and 5% of malignant germ-cell tumors in men arise at extragonadal sites. Of extragonadal germ cell tumors, testicular carcinoma in situ (CIS) are present in 31–42% of cases, and CIS are reported to have low sensitivity to chemotherapy in spite of the various morphology and to have a high likelihood of developing into testicular tumors. A testicular biopsy may thus be highly advisable when evaluating an extragonadal germ cell tumor.
A 36-year-old man was diagnosed as having an extragonadal non-seminomatous germ cell tumor, that was treated by cisplatin-based chemotherapy, leading to a complete remission. In the meantime, testicular tumors were not detected by means of ultrasonography. About 4 years later, a right testicular tumor was found, and orchiectomy was carried out. Microscopically, the tumor was composed of seminoma.
We herein report a case of metachronous occurrence of an extragonadal and gonadal germ cell tumor. In the evaluation of an extragonadal germ cell tumor, a histological examination should be included since ultrasonography is not sufficient to detect CIS or minute lesions of the testis.
Between 2% and 5% of malignant germ-cell tumors in men arise at extragonadal sites . Cytogenetically most extragonadal germ-cell tumors (EGGCTs) i.e., the seminomas and non-seminomas, are similar to their testicular counterparts [2, 3]. But there are CIS in 31–42% of EGGCT patients' testes . Ultrastructural studies indicate that CIS originate from rather primitive cells and can develop into different categories of germ cell carcinomas. Furthermore, since CIS are reported to respond poorly to chemotherapies, a metachronous development of testicular cancer will possibly occur, in spite of the various morphologies of testicular cancer [5, 6]. In the present case, the etiology of a metachronous appearance of EGGCT and testicular cancer is discussed.
There are reports that approximately 4% of patients with EGGCT develop a metachronous testicular cancer despite the use of cisplatin-based chemotherapy , and the cumulative risk of developing a metachronous testicular cancer 10 years after a diagnosis of EGGCT is 10.3% . However, there is disagreement over whether EGGCT is a primary disease or metastatic from the burned-out primary testicular lesion. Actually, burned-out tumors have been detected in 76% of cases of EGGCT . CIS is also found via biopsy in 31–42% cases [4, 10]. Testicular CIS is thought to have resistance to systemic chemotherapies and to develop later to metachronous testicular cancer. In the present case, the EGGCT was a non-seminomatous germ cell tumor including a yolk sac component, whereas the testicular cancer was a seminoma. We believe CIS was present at the time of the treatment of EGGCT and testicular CIS is so primitive that it could differentiate into any type of germ cells. It is also possible that these metachronously developing germ cell tumors developed independently. A testicular biopsy could clarify the relationship between these tumor cells and the expansion of the disease. In the present case no biopsy was done, but an ultrasonic examination ruled out the possibility of testicular CIS. Giwercman et al.  emphasized the necessity of histological examinations of the testis upon an evaluation of EGGCT [12–14] and also urged a careful follow-up for patients with EGGCT who do not have simultaneous testicular cancer.
On the other hand, there is an opinion that any patients with retroperitoneal masses should undergo scrotal ultrasound. Comiter et al.  showed definite pathological evidence of a burned-out testicular carcinoma in 5 of 6 patients (83%) with presumed extragonadal germ cell tumors and concluded that scrotal ultrasound studies are useful for the evaluation of the palpably normal testes . Kitahara et al. reviewed the incidence of scrotal echogenic leisions with testicular cancers or burned-out tumors of 22 EGGCT patients and found echogenic changes in 17 patients (77.3%) . This means that disease was overlooked by ultrasonic examinations in 22.7% of cases.
In our case, it is possibile that metachronous testicular cancer oriented in testicular CIS, grew from a burned-out tumor, or was independent of the EGGCT. We should have performed testicular biopsies at the time of the diagnosis of EGGCT and reflect the strategies of treatments of EGGCT.
Our proposed surveillance protocol of EGGCT is as below.
At the time of the diagnosis
Self-check of the testis
Scrotal ultrasound study
every 3 months
every 6 months
every 3 months
every 6 months
every 3 months
every 6 months
As we mentioned, the overall risk of development a testicular tumor is not so high(4–10.3%).
The side effect of CIS therapy (whether irradaition, orchiectomy or chemotherapy) are significant, especially concerning fertility and androgen production.
Testicular tumors early detected by adequate surveillance respond well to treatments.
Testicular biopsy is not entitled to detect all the CIS.
We thank the patient for giving consent for publication of this case report.
- Dueland S, Stenwig AE, Heilo A, Hoie J, Ous S, Fossa SD: Treatment and outcome of patients with extragonadal germ cell tumours – the Norwegian Radium Hospital's experience 1979–94. Br J Cancer. 1998, 77: 329-35.View ArticlePubMedPubMed CentralGoogle Scholar
- Chaganti RS, Rodriguez E, Mathew S: Origin of adult male mediastinal germ-cell tumours. Lancet. 1994, 343: 1130-2. 10.1016/S0140-6736(94)90235-6.View ArticlePubMedGoogle Scholar
- de Bruin TW, Slater RM, Defferrari R, Geurts van Kessel A, Suijkerbuijk RF, Jansen G, de Jong B, Oosterhuis JW: Isochromosome 12p-positive pineal germ cell tumor. Cancer Res. 1994, 54: 1542-4.PubMedGoogle Scholar
- Daugaard G, Rorth M, Cvon der Maase H, et al: Management of extragonadal germ-cell tumors and the significance of bilateral testicular biopsies. Ann Oncol. 1992, 3: 283-289.PubMedGoogle Scholar
- Reinberg Y, Manivel JC, Fraley EE: Carcinoma in situ of the testis. J Urol. 1989, 142: 243-247.PubMedGoogle Scholar
- Skakkebaek NE: Carcionam in situ of the testis: frequency and relationship to invasive germ cell tumors in infertile men. Histopathology. 1978, 2: 157-View ArticlePubMedGoogle Scholar
- Harland SJ, Cook PA, Fossa SD, et al: Risk factors for carcinoma in situ of the contralateral testis in patients with testicular cancer. Eur Urol. 1993, 23: 115-118. An interim reportPubMedGoogle Scholar
- Bokemeyer C, Hartmann JT, Fossa SD, Droz JP, Schmol HJ, Horwich A, Gerl A, Beyer J, Pont J, Kanz L, Nichols CR, Einhorn L: Extragonadal germ cell tumors: relation to testicular neoplasia and management options. APMIS. 2003, 111: 49-59. 10.1034/j.1600-0463.2003.11101081.x. discussion 59-63View ArticlePubMedGoogle Scholar
- Scholz M, Zehender M, Thalmann GN, Borner M, Thoni H, Studer UE: Extragonadal retroperitoneal germ cell tumor: evidence of origin in the testis. Ann Oncol. 2002, 13: 121-4. 10.1093/annonc/mdf003.View ArticlePubMedGoogle Scholar
- Fossa SD, Aass N, Heilo A, Daugaard G, Skakkebaek NE, Stenwig AE, Nesland JM, Looijenga LH, Oosterhuis JW: Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsy. Ann Oncol. 2003, 14: 1412-8. 10.1093/annonc/mdg373.View ArticlePubMedGoogle Scholar
- Giwercman A, von der M aase H, Skakkebaek NE: Epidemiological and clinical aspects of carcinoma in situ of the testis. Eur Urol. 1993, 23: 104-10. discussion 111-4PubMedGoogle Scholar
- Mumperow G, Lauke H, Holstein AF, et al: Further practical experiences in the recognition and the management of carcinoma in situ of the testis. Urol Int. 1992, 48: 162-166.View ArticlePubMedGoogle Scholar
- Gleich P: Testicular carcinoma in situ and nonpalpable seminoma eight years after contralateral teratocarcinoma. Urology. 1990, 36: 181-182.View ArticlePubMedGoogle Scholar
- Kimura F, Watanabe S, Shimizu S, Nakajima F, Hayakawa M, Nakamura H: Primary seminoma of the prostate and embryonal cell carcinoma of the left testis in one patient: a case report. Jpn J Urol. 1995, 86: 1497-1500.View ArticleGoogle Scholar
- Comiter CV, Benson CJ, Capelouto CC, Kantoff P, Shulman L, Richie JP, Loughlin KR: Nonpalpable intratesticular masses detected sonographically. J Urol. 1995, 154: 1367-9. 10.1097/00005392-199510000-00029.View ArticlePubMedGoogle Scholar
- Kitahara K, Hori J, Tokumitsu M, Saga Y, Hashimoto H, Kaneko S, Yachiku S: Retroperitoneal germ cell tumor with testicular calcification indicating tiny testicular origin: consideration of the origin of retroperitoneal germ cell tumors: report of two cases Hinyokika Kiyo. Review Japanese. 2003, 49: 291-5.Google Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2490/4/13/prepub